drugset / Trial / NCT00275002

O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem Tumors

NCT00275002

Phase 2 Completed 41 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

This phase II trial is studying how well giving O6-benzylguanine together with temozolomide works in treating young patients with recurrent or progressive gliomas or brain stem tumors. Drugs used in chemotherapy, such as O6-benzylguanine and temozolomide , work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. O6-benzylguanine may help temozolomide work better by making tumor cells more sensitive to the drug. Giving more than one drug (combination chemotherapy) may kill more tumor cells.

Timeline

Start
2006-02
Primary completion
2010-12-01
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject O6-benzylguanine Small molecule 120 mg/m2 Intravenous
Subject Temozolomide Small molecule 75 mg/m2 Oral